No definition available.
Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
314 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
based on the number of shared cases.
Similar with more cases:
- Venous thromboembolism
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 174 | 140 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 50.63 | 47.30 | 54.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 291
- Matched controls
- 2911
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
+∞
323.0
291
44
B01AA03
ATC
warfarin; systemic
12.3
81.5
205
472
B01AB04
ATC
dalteparin; parenteral
11.9
33.0
63
66
M79.6
ICD-10 Finland
Pain in limb
3.5
21.8
146
653
B01AB05
ATC
enoxaparin; parenteral
3.5
21.5
138
595
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
10.4
20.7
41
45
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
8.5
16.8
37
49
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
19.1
15.4
23
13
D68.8
ICD-10 Finland
Other specified coagulation defects
56.2
14.0
16
*
K94
ICPC
Phlebitis/thrombophlebitis
22.5
13.5
19
9
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.9
13.3
58
173
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
12.4
13.1
23
20
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
10.8
12.7
24
24
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
17.3
11.8
18
11
I87.0
ICD-10 Finland
Postthrombotic syndrome
124.7
11.5
12
*
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
16.3
11.0
17
11
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
12.0
9.7
17
15
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.4
9.5
48
161
N02AX02
ATC
tramadol; systemic, rectal
2.2
9.4
143
892
J01DA01
ATC
[U] cefalexin; systemic
2.2
9.1
199
1444
K93
ICPC
Pulmonary embolism
13.3
8.5
14
11
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
8.4
31
80
ZXE00
NOMESCO Finland
One hour or less
2.1
8.1
130
813
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
7.6
7.3
16
22
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
7.3
107
639
A46
ICD-10 Finland
Erysipelas
2.6
7.1
56
246
D01AC02
ATC
miconazole; topical
3.1
7.0
37
129
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
41.0
6.8
8
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
6.5
99
595
M01AH02
ATC
rofecoxib; oral
2.6
6.2
48
208
J01DB01
ATC
cefalexin; oral
2.0
6.1
231
1904
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
533
2.35
10.65
2.2
1.7
mg/l
1.8
1.2
0.80
74
431
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
76
3.64
7.85
5.5
1.9
u/ml
0.3
0.3
0.01
16
37
(3032080) INR in Blood by Coagulation assay
158
1091
1.90
7.21
29.5
9.8
inr
1.7
1.3
3.61
62
307
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
6
314
0.18
7.21
3.7
4.6
%
33.3
32.5
—
6
199
(40761536) Microorganisms panel - Urine sediment
47
205
2.52
7.10
5.1
4.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
155
1071
1.88
6.99
15.2
10.3
e9/l
0.0
0.0
0.55
133
898
(3018418) pH of Serum or Plasma
124
801
1.91
6.86
5.6
3.9
ph
7.4
7.4
0.17
31
154
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
290
2.27
6.84
1.8
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
294
2.24
6.61
1.8
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
154
1106
1.77
5.78
5.8
4.4
g/l
34.2
35.0
0.99
142
1034
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
269
2.17
5.65
4.6
3.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
115
775
1.76
5.26
4.3
3.3
u/l
31.1
31.2
0.02
108
740
(42870588) Differential panel, method unspecified - Blood
119
813
1.75
5.17
7.9
5.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
52
271
2.10
5.17
2.0
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
45
223
2.19
5.08
3.8
4.2
mmol/l
1.2
1.2
0.12
36
197
(3026008) Bacteria identified in Urine by Culture
118
810
1.73
5.01
3.4
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
130
920
1.70
4.93
3.8
4.0
e6/l
53.8
84.1
0.66
96
667
(3030467) Casts [#/volume] in Urine by Automated count
109
736
1.74
4.89
3.4
3.3
e6/l
0.4
0.5
0.22
84
550
(3002582) Erythrocytes [#/volume] in Urine
116
805
1.70
4.68
3.3
3.4
e6/l
42.0
139.4
0.62
94
619
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
70
420
1.86
4.64
2.0
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
54
298
1.98
4.59
8.0
6.5
mmol/l
2.2
1.3
0.76
47
225
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
8
10.22
4.54
1.8
3.1
u/ml
1521.0
796.1
—
8
8
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
31
3.99
4.29
1.0
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
102
698
1.68
4.27
3.6
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
130
948
1.63
4.24
3.6
3.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
500
1.75
4.12
5.4
3.9
ng/l
208.7
157.0
0.18
69
414
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
47
3.30
4.11
3.2
2.7
e9/l
4.7
4.7
0.02
15
47
(4034850)
22
88
2.61
3.97
7.7
10.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
327
0.31
3.89
7.2
8.0
—
—
—
0
0
(3026782) Osmolality of Urine
83
550
1.69
3.87
3.0
3.0
mosm/kgh2o
535.7
559.6
0.55
75
463
(3013826) Glucose [Moles/volume] in Serum or Plasma
184
1480
1.59
3.87
6.5
4.5
mmol/l
6.7
6.8
0.14
174
1391
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
49
3.16
3.86
3.3
3.2
%
62.4
58.9
0.47
15
49
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
44
240
1.97
3.86
2.2
2.4
u/l
24.2
32.6
1.43
36
199
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
128
2.30
3.83
9.9
8.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
35
176
2.11
3.81
4.3
4.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
79
519
1.70
3.80
4.3
5.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
104
738
1.61
3.69
6.4
4.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
208
2.00
3.64
10.5
7.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
92
640
1.62
3.52
2.3
2.1
mg/l
3.2
3.2
0.01
78
552
(3001122) Ferritin [Mass/volume] in Serum or Plasma
133
1020
1.53
3.29
3.1
2.6
ug/l
110.2
141.4
0.99
122
931
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
49
2.94
3.23
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
49
2.94
3.23
1.4
1.5
—
—
—
0
0
(4306422)
10
28
3.66
3.22
1.2
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
781
1.54
3.12
4.0
3.9
mg/mmol
13.1
10.0
0.20
75
492
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
67
443
1.65
3.11
2.5
2.8
e6/l
1.3
1.2
0.08
37
256
(3009508) Creatinine [Moles/volume] in Urine
103
756
1.54
3.08
2.8
3.0
mmol/l
6.9
7.2
0.25
94
623
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
112
845
1.51
2.92
3.4
3.2
ng/l
2073.5
1590.5
0.37
94
717
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
222
1924
1.53
2.90
10.4
7.5
u/l
81.6
79.6
0.19
212
1790
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
46
280
1.75
2.88
3.2
2.7
umol/l
13.1
7.8
0.52
40
251
(3022145) Colonoscopy Study observation
46
281
1.75
2.85
1.4
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
152
1225
1.47
2.83
3.9
4.0
estimate
0.0
0.0
0.00
44
234
(3044889) 12 lead EKG panel
206
1762
1.49
2.83
5.2
4.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
153
1235
1.47
2.83
8.2
5.9
e9/l
0.2
0.2
0.27
137
1092
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
63
420
1.63
2.82
2.7
3.1
e6/l
3.8
2.5
0.33
34
234
(3021447) Carbon dioxide [Partial pressure] in Venous blood
42
251
1.78
2.80
5.1
3.4
kpa
6.1
5.7
1.39
42
241
(3000850) Epithelial cells [#/volume] in Urine
79
558
1.56
2.78
2.9
2.7
e6/l
8.8
5.0
1.16
70
486
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
6
8.44
2.76
2.0
3.2
%
89.2
96.0
—
5
6
(1616796) Gas panel - Central venous blood
15
60
2.58
2.74
11.7
2.9
—
—
—
0
0
(44813793)
6
10
6.09
2.71
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
152
1233
1.45
2.70
5.0
5.4
estimate
0.0
0.0
0.00
43
234
(3021960) Folate [Moles/volume] in Serum or Plasma
88
643
1.51
2.64
1.6
1.5
nmol/l
17.2
21.5
3.25
78
531
(3009261) Glucose [Presence] in Urine by Test strip
152
1240
1.44
2.58
4.0
4.0
estimate
0.0
0.0
0.00
43
226
(3001604) Monocytes [#/volume] in Blood
147
1193
1.44
2.57
7.7
5.6
e9/l
0.6
0.6
0.60
128
1031
(3002032) Base excess in Venous blood by calculation
41
250
1.74
2.56
5.1
3.4
mmol/l
2.4
2.0
0.21
32
192
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
7
7.24
2.56
2.2
9.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
98
737
1.48
2.55
3.0
3.1
mg/l
61.2
234.7
0.76
64
464
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
10
33
3.10
2.55
1.2
1.1
u/ml
18.8
4.5
—
5
16
(3012544) pH of Venous blood
42
259
1.72
2.52
5.3
3.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
87
641
1.49
2.50
3.0
2.8
umol/l
5427.4
5494.5
0.00
79
542
(3006315) Basophils [#/volume] in Blood
147
1198
1.43
2.48
7.7
5.6
e9/l
0.0
0.0
0.59
128
1039
(3013650) Neutrophils [#/volume] in Blood by Automated count
167
1393
1.42
2.48
10.6
9.4
e9/l
4.5
4.1
1.32
151
1217
(3015377) Calcium [Moles/volume] in Serum or Plasma
115
897
1.45
2.46
3.0
3.3
mmol/l
2.3
2.3
0.53
104
778
(40758558) Short blood count panel - Blood
85
625
1.49
2.46
10.8
7.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
145
1181
1.42
2.45
8.6
5.4
mmol/l
1.2
1.2
0.17
134
1062
(3022806) Fractional oxyhemoglobin in Capillary blood
10
34
3.01
2.43
3.4
1.9
%
89.5
89.7
—
10
34
(3048689) Calprotectin [Mass/mass] in Stool
41
256
1.69
2.36
2.2
2.2
ug/g
217.0
150.0
0.33
33
206
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
159
1328
1.40
2.27
7.3
6.3
umol/l
13.5
11.3
0.58
153
1259
(3022096) Basophils/100 leukocytes in Blood
134
1088
1.40
2.26
7.8
5.6
%
0.7
0.7
0.33
126
1008
(3011397) Hemoglobin [Presence] in Urine by Test strip
77
565
1.48
2.24
3.2
4.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
137
1118
1.40
2.23
7.7
5.6
%
2.8
2.8
0.01
129
1035
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
513
1.50
2.22
2.7
3.1
mmol/l
2.5
2.5
0.12
63
443
(3019069) Monocytes/100 leukocytes in Blood
137
1119
1.40
2.22
7.7
5.9
%
8.8
8.7
0.11
129
1043
(3019225) pH of Specimen
10
237
0.40
2.22
4.7
3.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
124
1001
1.39
2.13
2.6
2.2
nmol/l
73.9
78.3
1.16
116
883
(3019198) Lymphocytes [#/volume] in Blood
147
1224
1.38
2.09
7.8
5.6
e9/l
1.7
1.9
0.85
131
1085
(3037522) Nuclear Ab [Titer] in Serum
44
291
1.60
2.04
1.4
1.4
titre
488.0
524.7
—
10
68
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
187
1.73
2.03
1.5
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
57
2.34
2.00
7.2
2.7
%
15.7
15.3
—
7
30
(3002030) Lymphocytes/100 leukocytes in Blood
137
1141
1.36
1.89
7.7
5.8
%
25.8
26.9
0.59
129
1059
(3023410) Appearance of Cerebral spinal fluid
7
22
3.23
1.89
3.7
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
40
2.55
1.85
2.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
17
3.58
1.84
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
193
1698
1.35
1.84
5.0
4.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
6
154
0.38
1.81
1.2
2.3
e9/l
4.9
3.9
—
6
115
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
126
1043
1.35
1.79
2.3
2.0
pmol/l
89.3
93.7
0.58
73
533
(3042936) Bacteria identified in Isolate by Culture
53
377
1.49
1.79
2.4
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
101
808
1.37
1.79
2.8
2.3
u/l
47.9
56.7
3.21
96
739
(3000494) Fungus identified in Specimen by Culture
43
293
1.54
1.77
1.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
18
3.38
1.75
2.8
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
30
2.71
1.73
1.1
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
47
329
1.50
1.72
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
46
321
1.51
1.70
1.3
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
55
400
1.45
1.67
3.2
2.4
umol/l
10.9
12.6
1.16
50
371
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
349
1.48
1.65
3.5
2.4
%
16.7
21.8
2.18
39
306
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
154
1.68
1.55
1.4
1.8
—
—
—
0
0
(3020891) Body temperature
19
108
1.81
1.54
4.7
4.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
201
1804
1.32
1.54
4.4
3.8
pmol/l
15.3
14.9
1.05
184
1604
(3024354) Oxygen [Partial pressure] in Venous blood
32
212
1.57
1.50
3.8
2.8
kpa
4.0
4.3
0.38
32
202
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
9
40
2.29
1.41
1.4
1.1
u/l
25.2
30.4
—
9
32
(3018010) Neutrophils/100 leukocytes in Blood
131
1123
1.29
1.37
7.8
5.6
%
59.1
57.9
0.52
122
1047
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
39
0.00
1.34
0.0
2.9
—
19.6
—
0
9
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
54
2.07
1.34
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
227
1.51
1.33
1.6
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
18
2.81
1.29
1.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
35
2.32
1.27
2.3
3.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
147
1.61
1.27
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
25
2.43
1.25
5.5
2.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
25
2.43
1.25
1.2
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
19
117
1.66
1.21
3.1
3.2
u/ml
501.6
2487.4
0.71
11
102
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
146
1285
1.25
1.19
3.0
2.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
95
1.72
1.16
2.2
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
20
2.52
1.15
1.6
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
30
2.36
1.13
1.1
2.2
pg
33.0
32.2
—
7
30
(3029937) Albumin [Presence] in Urine by Test strip
82
681
1.28
1.08
5.2
4.3
estimate
0.0
0.0
0.00
41
229
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
254
2399
1.31
1.08
25.0
15.5
mg/l
22.2
24.3
0.61
217
1933
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
47
1.94
1.03
1.1
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
145
1293
1.23
1.01
8.9
6.1
mmol/l
1.2
1.2
0.37
111
1079
(3023419) Bacteria identified in Sputum by Culture
7
35
2.02
1.00
2.0
2.7
—
—
—
0
0
(4268621)
5
23
2.19
0.98
2.4
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
117
1025
1.23
0.96
5.5
4.1
ng/l
39.6
45.2
0.12
77
769
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
164
1489
1.21
0.93
4.1
3.0
u/l
65.8
49.3
0.96
148
1378
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
52
1.75
0.93
4.3
2.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
170
0.57
0.93
2.8
2.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
63
1.77
0.91
5.9
2.5
kpa
7.4
7.9
0.33
11
56
(21494755) Public health laboratory ask at order entry panel
9
154
0.57
0.91
1.8
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
29
2.09
0.90
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
79
1.67
0.89
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
42
1.93
0.89
1.1
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
64
1.74
0.87
1.2
1.6
—
—
—
0
0
(1002224) Polysomnography panel
14
88
1.62
0.86
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
91
785
1.22
0.86
2.8
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
233
2202
1.23
0.83
5.5
4.6
mu/l
2.0
2.5
0.42
216
1975
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
73
1.67
0.83
1.9
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
126
1126
1.20
0.82
5.3
4.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
66
1.69
0.79
1.2
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
24
0.00
0.79
0.0
1.7
—
3.7
—
0
7
(3052851) Hemolysis interference index of Serum or Plasma
12
74
1.65
0.79
6.5
3.2
—
—
—
0
0
(4146454)
0
26
0.00
0.79
0.0
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
34
1.78
0.76
1.2
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
59
1.72
0.76
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
68
576
1.23
0.76
2.0
1.8
pmol/l
479.6
439.9
0.37
53
473
(40768804) Tissue Pathology biopsy report
113
1007
1.19
0.75
2.5
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
40
1.77
0.71
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
78
1.56
0.66
1.3
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
297
1.28
0.66
3.7
4.3
ug/l
36.0
43.5
0.07
31
248
(3008898) HLA-B27 [Presence]
11
70
1.59
0.66
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
88
779
1.18
0.63
2.3
2.0
u/l
208.0
178.3
0.15
81
728
(3013512) EKG study
69
790
0.84
0.62
4.8
4.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
9
139
0.64
0.62
6.8
2.9
u/ml
31.8
33.6
—
9
133
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
50
1.62
0.61
2.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
20
0.00
0.60
0.0
2.0
—
0.8
—
0
9
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
20
0.00
0.60
0.0
2.1
—
558.0
—
0
8
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
20
0.00
0.60
0.0
4.0
—
—
—
0
0
(4024509)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
52
1.55
0.60
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
115
0.60
0.59
2.3
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
37
1.63
0.56
1.3
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
61
1.49
0.54
1.1
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
408
1.21
0.54
1.4
1.3
iu/ml
10.9
43.6
—
9
136
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
169
0.70
0.53
2.2
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
390
1.21
0.53
1.3
1.3
u/ml
4.7
10.8
0.84
15
161
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
236
2268
1.16
0.53
7.1
6.1
mmol/mol
41.7
40.5
1.18
223
2102
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
107
976
1.15
0.52
4.6
4.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
162
1.32
0.51
2.1
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
65
1.40
0.51
1.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
47
546
0.84
0.50
4.1
4.4
—
1.0
—
0
79
(3022313) Gas panel - Capillary blood
7
108
0.64
0.49
1.3
3.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
192
1828
1.13
0.46
5.8
4.2
mm/h
15.8
13.3
1.06
180
1663
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
50
1.41
0.45
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
50
1.41
0.45
1.3
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
38
322
1.20
0.45
1.6
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
56
1.44
0.43
1.1
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
96
1.37
0.42
1.2
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
326
1.19
0.40
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
35
1.44
0.39
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
35
1.44
0.39
3.2
3.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
170
0.75
0.39
1.5
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
61
678
0.88
0.38
4.3
4.5
%
21.5
21.7
0.04
28
343
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
67
1.35
0.38
2.2
2.2
mg/l
9.9
11.7
—
9
60
(3012441) Differential panel - Pleural fluid
5
36
1.40
0.38
2.0
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
663
1.13
0.38
1.8
1.7
mmol/l
1.5
1.3
0.94
60
548
(3049717) Cytology report of Urine Cyto stain
8
114
0.69
0.38
1.6
2.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
27
228
1.20
0.34
1.9
2.9
e9/l
78.3
66.9
0.90
19
182
(3041096) Erythrocytes [Presence] in Urine by Automated
75
687
1.12
0.34
4.5
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
64
582
1.13
0.33
2.7
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
78
844
0.90
0.32
5.5
5.3
ug/l
2.3
3.0
0.53
69
740
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
54
487
1.13
0.32
1.4
1.2
u/ml
2.7
1.5
0.27
20
129
(3021901) Oxygen saturation in Capillary blood
7
53
1.33
0.31
8.6
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
107
0.74
0.29
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
489
0.88
0.29
2.7
3.2
ug/l
0.8
0.8
0.00
29
331
(46235355) HIV 1 and 2 tests - Meaningful Use set
22
257
0.85
0.27
1.9
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
141
1.22
0.26
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
59
542
1.11
0.26
1.9
1.8
nmol/l
1193.4
1142.0
0.16
48
411
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
74
0.67
0.26
5.8
2.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
78
1.29
0.24
5.1
2.3
mg/l
2.2
1.5
—
10
71
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
78
1.29
0.24
6.7
2.5
mmol/l
26.7
25.3
—
10
64
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
200
0.84
0.23
1.6
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
200
1.16
0.23
3.3
3.1
ml/min/173m2
66.6
63.6
0.12
11
89
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
222
2269
0.93
0.22
4.1
4.1
mmol/l
1.4
1.2
2.56
207
2058
(3003434) Protein [Mass/volume] in Pleural fluid
5
42
1.19
0.21
2.0
1.5
g/l
42.8
30.9
—
5
36
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
42
1.19
0.21
2.4
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
11
0.00
0.21
0.0
2.5
—
9.6
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
10
0.00
0.21
0.0
4.9
—
43.6
—
0
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
52
1.16
0.19
2.2
3.3
u/ml
15.8
30.7
—
6
52
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
82
1.23
0.17
1.6
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
148
1.16
0.17
4.4
3.5
mmol/l
4.0
2.2
0.63
11
116
(4094501)
5
66
0.75
0.17
1.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
223
2268
0.94
0.16
25.0
14.7
ml/min/173m2
76.1
76.2
0.04
199
1884
(40761535) Cells panel - Urine sediment
19
213
0.89
0.15
3.9
3.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
192
0.88
0.15
1.2
2.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
150
1.14
0.15
2.8
2.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
86
0.81
0.14
1.3
4.1
mmol/l
25.2
25.3
—
7
81
(3009542) Hematocrit [Volume Fraction] of Blood
215
2113
1.06
0.14
28.4
16.4
%
38.9
39.3
0.29
151
1420
(40761511) CBC panel - Blood by Automated count
247
2502
0.94
0.14
22.5
14.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
84
1.20
0.14
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
133
1.13
0.12
1.1
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
147
0.88
0.11
4.1
4.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
255
2523
1.06
0.11
28.5
17.9
mmol/l
139.9
139.7
0.66
250
2452
(4035726)
25
231
1.09
0.11
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
47
447
1.06
0.10
1.5
1.4
g/l
2.6
2.6
0.08
26
265
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
239
2364
1.05
0.10
5.1
4.7
mmol/l
6.3
6.0
3.05
221
2134
(3023103) Potassium [Moles/volume] in Serum or Plasma
255
2526
1.05
0.10
29.2
18.0
mmol/l
4.0
4.0
0.65
250
2453
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
46
1.09
0.09
2.0
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
54
1.11
0.09
2.7
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
113
0.88
0.08
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
17
157
1.09
0.07
4.4
3.4
ph
7.4
7.4
—
7
20
(3043409) Potassium [Moles/volume] in Arterial blood
9
88
1.02
0.07
3.9
3.8
mmol/l
3.7
4.0
—
9
81
(1761482) Bacteria [#/volume] in Urine by Culture
8
94
0.85
0.07
4.8
5.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
100
0.90
0.06
2.4
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
257
2553
1.04
0.06
14.9
10.7
u/l
26.9
24.5
1.53
249
2460
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
234
2356
0.97
0.05
4.4
4.5
mmol/l
1.4
1.5
2.05
219
2143
(1761868) Lipid panel - Serum or Plasma
83
814
1.03
0.05
3.8
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
23
219
1.05
0.04
1.7
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
244
2426
1.03
0.04
5.6
5.1
mmol/l
2.6
2.7
0.51
228
2210
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
111
1.08
0.04
1.6
1.6
—
—
—
0
0
(3000492) Spirometry study
22
210
1.05
0.03
1.4
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
17
161
1.06
0.03
4.4
3.4
kpa
5.3
5.1
0.23
17
148
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
128
0.94
0.02
1.7
1.7
—
—
—
0
0
(4010399)
18
188
0.95
0.02
1.2
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
263
2639
0.98
0.02
34.4
22.6
e9/l
6.9
6.7
0.56
258
2558
(3026361) Erythrocytes [#/volume] in Blood
263
2639
0.98
0.02
34.4
22.6
e12/l
4.4
4.4
0.17
257
2560
(3007461) Platelets [#/volume] in Blood
263
2638
0.98
0.01
34.4
22.6
e9/l
250.2
246.7
0.32
258
2567
(3020564) Creatinine [Moles/volume] in Serum or Plasma
254
2548
0.98
0.01
29.5
18.3
umol/l
82.1
79.4
0.49
254
2548
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
108
1.02
0.00
1.2
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
133
0.98
0.00
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
237
2373
0.99
0.00
4.5
4.6
mmol/l
4.5
4.6
0.92
221
2177
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.0
—
859.7
—
0
9
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.1
—
6.1
—
0
9
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
17.7
—
1488.3
—
0
9
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
82
0.97
0.00
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
67
0.89
0.00
1.2
1.4
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
88
0.91
0.00
2.0
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
85.0
—
0
8
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
1.6
—
0
7
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
3.3
—
0
6
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
82
0.97
0.00
1.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
57
570
1.00
0.00
1.4
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
59
1.02
0.00
6.0
2.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
24.7
—
0
6
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
54
0.92
0.00
1.2
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
60
1.00
0.00
1.3
5.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
81
0.99
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE – Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
GWS hits: 1
This endpoint is excluded (not available in FinRegistry).